​Chr. Hansen’s latest launch secures rich flavor, more flexibility and consistent quality for the cheesemaker

Clinical trial demonstrates that probiotic strain strengthens the defense against gut damage caused by regular use of household painkiller

​Chr. Hansen Holding A/S has entered into an agreement with Klaus Bjerrum to take up the position of Executive Vice President of Natural Colors Division

Prota Therapeutics, the developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen. The partnership will assess the world’s best documented probiotic strain, LGG®, in a Phase III clinical trial to develop a treatment for peanut allergy.

As the conversion wave from synthetic to natural colors continues to rise in the US market, Chr. Hansen gears up for the future

"We are satisfied with the progress in the first half of the year, and we maintain our overall guidance for the full year,” says CEO Cees de Jong

Pocket size, NIR spectrometer transforms feed analysis by enabling real-time, on-farm forage analysis - Chr. Hansen equips their nutritionists and distributors first, followed by all customers.

Jørgen Erichsen, Executive Vice President of the Natural Colors Division, will leave the position as Executive Vice President effective today, 2 February 2018.

​EVP Christoffer Lorenzen has been appointed member of the Executive Board of Chr. Hansen Holding A/S.

Bioprotection continues to show impressive momentum